CN105641336A

CN105641336A - Traditional Chinese medicine oral medicament for treating acne

Info

Publication number: CN105641336A
Application number: CN201410625350.7A
Authority: CN
Inventors: 张亚洁
Original assignee: Nanjing Haoding Biotechnology Co Ltd
Current assignee: Nanjing Haoding Biotechnology Co Ltd
Priority date: 2014-11-10
Filing date: 2014-11-10
Publication date: 2016-06-08

Abstract

The invention discloses a traditional Chinese medicine oral medicament for treating acne. The traditional Chinese medicine oral medicament comprises the following raw material components in percentage by mass: 5-10% of radix et rhizoma rhei, 6-8% of sporophore of ganoderma lucidum, 2-3% of phillyrin, 1-3% of spica prunellae, 3-4% of aloe, 2-3% of flos lonicerae, 3-5% of liquiritigenin, 9-15% of chrysanthemum, 15-20% of radix salviae miltiorrhizae, 11-18% of radix astragali, 4-8% of herba lysimachiae, 3-6% of herba asari, 8-11% of fructus schisandrae chinensis, 4-7% of folium eriobotryae and 3-6% of herb of knottedflower phyla. The provided traditional Chinese medicine oral medicament for treating acne is convenient to take and excellent in acne treating effect, adopts natural plants or extracts thereof as basic raw materials, and is free of toxic and side effects on the human body.

Description

A kind of extract oral medicament treating acne

Technical field

The present invention relates to field of medicine preparations, disclose a kind of extract oral medicament treating acne.

Background technology

Acne are a kind of common diseases, and severe patient affects patient's beauty treatment, makes patient produce inferiority complex, affect their normal contacts. At present, the treatment acne medicine that market is sold is mostly external application type chemicals, poor effect, in-convenience in use, and its composition is mostly chemical industry synthetic, and human body has certain toxic action.

Summary of the invention

The present invention provides a kind of extract oral medicament treating acne, taking convenience, treats acne excellent, and with natural plants or its extract for base stock, to human non-toxic's side effect.

In order to reach above technique effect, technical scheme is as follows:

A kind of extract oral medicament treating acne, raw material includes following components by percentage to the quality:

Radix Et Rhizoma Rhei 5-10%;

Ganoderma 6-8%;

Phillyrin 2-3%;

Spica Prunellae 1-3%;

Aloe 3-4%;

Flos Lonicerae 2-3%;

Glycyrrhizin 3-5%;

Flos Chrysanthemi 9-15%;

Radix Salviae Miltiorrhizae 15-20%;

Radix Astragali 11-18%;

Herba Lysimachiae 4-8%;

Herba Asari 3-6%;

Fructus Schisandrae Chinensis 8-11%;

Folium Eriobotryae 4-7%;

Herba phylae nodieflorae 3-6%.

Preferably, raw material includes following components by percentage to the quality:

Radix Et Rhizoma Rhei 8%;

Ganoderma 7%;

Phillyrin 3%;

Spica Prunellae 2%;

Aloe 3%;

Flos Lonicerae 3%;

Glycyrrhizin 4%;

Flos Chrysanthemi 10%;

Radix Salviae Miltiorrhizae 16%;

The Radix Astragali 14%;

Herba Lysimachiae 6%;

Herba Asari 4%;

Fructus Schisandrae Chinensis 9%;

Folium Eriobotryae 6%;

Herba phylae nodieflorae 5%.

Beneficial effects of the present invention:

Detailed description of the invention

Describing technical scheme in detail below in conjunction with specific embodiment, illustrative examples and explanation in this present invention are used for explaining technical scheme, but not as a limitation of the invention.

Embodiment 1:

Radix Et Rhizoma Rhei 8%;

Ganoderma 7%;

Phillyrin 3%;

Spica Prunellae 2%;

Aloe 3%;

Flos Lonicerae 3%;

Glycyrrhizin 4%;

Flos Chrysanthemi 10%;

Radix Salviae Miltiorrhizae 16%;

The Radix Astragali 14%;

Herba Lysimachiae 6%;

Herba Asari 4%;

Fructus Schisandrae Chinensis 9%;

Folium Eriobotryae 6%;

Herba phylae nodieflorae 5%.

The above is the preferred embodiment of the present invention; it should be pointed out that, for those skilled in the art, under the premise without departing from the principles of the invention; can also making some improvements and modifications, these improvements and modifications are also considered as protection scope of the present invention.

Claims

1. the extract oral medicament treating acne, it is characterised in that: raw material includes following components by percentage to the quality:

Radix Et Rhizoma Rhei 5-10%;

Ganoderma 6-8%;

Phillyrin 2-3%;

Spica Prunellae 1-3%;

Aloe 3-4%;

Flos Lonicerae 2-3%;

Glycyrrhizin 3-5%;

Flos Chrysanthemi 9-15%;

Radix Salviae Miltiorrhizae 15-20%;

Radix Astragali 11-18%;

Herba Lysimachiae 4-8%;

Herba Asari 3-6%;

Fructus Schisandrae Chinensis 8-11%;

Folium Eriobotryae 4-7%;

Herba phylae nodieflorae 3-6%.

2. a kind of extract oral medicament treating acne according to claim 1, it is characterised in that: raw material includes following components by percentage to the quality:

Radix Et Rhizoma Rhei 8%;

Ganoderma 7%;

Phillyrin 3%;

Spica Prunellae 2%;

Aloe 3%;

Flos Lonicerae 3%;

Glycyrrhizin 4%;

Flos Chrysanthemi 10%;

Radix Salviae Miltiorrhizae 16%;

The Radix Astragali 14%;

Herba Lysimachiae 6%;

Herba Asari 4%;

Fructus Schisandrae Chinensis 9%;

Folium Eriobotryae 6%;

Herba phylae nodieflorae 5%.